Vimentin Recombinant Rabbit mAb (SDT-029-20) Drug Target Proteins and the residual kanamycin in

and the residual kanamycin in the sample competes with the conjugated antigen pre coated on the microporous strip for anti kanamycin antibodies

Species Human Synonyms rHuGRO-β/CXCL2

PDL1 is a cell surface immunoglobulin superfamily with two Ig-like domains within the extracellular region and a short cytoplasmic domain

There are now four LAG3-targeted therapies in the clinic with many more in preclinical development [PMID: 28258692]

FIP/BIP Primers (25X)

Vimentin Recombinant Rabbit mAb (SDT-029-20) Drug Target Proteins and the residual kanamycin inProduct Specification Host Rabbit Antigen Vimentin Immunogen Synthetic Peptide Accession P08670 Clone Number SDT 029 20 Antibody Type Rabbit mAb Isotype IgG Application WB, IHC P, ICC, IF Reactivity Hu, Ms, Rt Predicted Reactivity Pr, Bv, Cz, Pg, Hm, Av Purification Protein A Research Area Neuroscience Concentration 1 mg ml Molecular Weight 56kDa Conjugation Unconjugated Physical Appearance Liquid Storage Buffer PBS, 40% Glycerol, 0. 05%BSA, 0. 03%